Upcoming Investor Conferences Featuring Celldex
Celldex (NASDAQ: CLDX) has exciting news for its investors and stakeholders. The company recently announced that its management team will participate in several significant fireside chats at various investor conferences. These conferences offer a prime opportunity for Celldex to showcase its innovative strategies and advancements in immunology.
Details of the Conferences
The conferences Celldex will attend include:
- Guggenheim 2nd Annual Healthcare Innovation Conference on a Tuesday
- TD Cowen Immunology & Inflammation Summit later in the week
- 8th Annual Evercore Healthcare Conference on a Tuesday afternoon
These appearances highlight the company’s commitment to connecting with investors and the healthcare community, sharing insights into their forward-thinking approaches and projects.
Live Webcasts and Presentations
For those unable to attend in person, live webcasts of the presentations will be accessible on the "Events & Presentations" page within the Investors section of the Celldex website. This is a great chance for investors to engage with the latest company updates and strategic insights directly from the leadership team. Following the events, replays of the presentations will remain available for 90 days, ensuring all interested parties have the opportunity to catch up on any discussions or key points.
About Celldex Therapeutics
Celldex is renowned for its pioneering work in immunology, focused on developing life-changing therapies. The company is dedicated to creating innovative antibody-based treatments that engage and enhance the human immune system, aiming to address critical pathways involved in various allergic, inflammatory, and autoimmune disorders. Through relentless pursuit of groundbreaking solutions, Celldex strives to improve the quality of life for patients across the spectrum of these challenging conditions.
Company Contact Information
For further inquiries, Celldex provides the following contact channels:
Sarah Cavanaugh
Senior Vice President, Corporate Affairs & Administration
(508) 864-8337
scavanaugh@celldex.com
Patrick Till
Meru Advisors
(484) 788-8560
ptill@meruadvisors.com
Frequently Asked Questions
What is the purpose of the conferences Celldex is attending?
The conferences aim to provide Celldex an opportunity to present its latest developments and innovations in immunology to investors and the wider healthcare community.
How can investors access the presentations if they cannot attend?
Investors can access live webcasts of the presentations on the Celldex website, and replays will be available for 90 days.
What is Celldex known for?
Celldex is known for pioneering antibody-based therapies aimed at enhancing the human immune system to treat various allergic, inflammatory, and autoimmune disorders.
Who can be contacted for more information?
Investors can contact Sarah Cavanaugh or Patrick Till for further information about Celldex and its future endeavors.
Where can I find more information about Celldex?
Additional information can be found on the Celldex website, where updates about their initiatives and investor relations are regularly posted.
